The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae. Issue 1 (1st January 2015)
- Record Type:
- Journal Article
- Title:
- The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae. Issue 1 (1st January 2015)
- Main Title:
- The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae
- Authors:
- Nerome, Kuniaki
Sugita, Shigeo
Kuroda, Kazumichi
Hirose, Toshiharu
Matsuda, Sayaka
Majima, Kei
Kawasaki, Kazunori
Shibata, Toshikatsu
Poetri, Okti Nadia
Soejoedono, Retno D.
Mayasari, Ni L.P. Ika
Agungpriyono, Srihadi
Nerome, Reiko - Abstract:
- <abstract abstract-type="author" id="abs0005"> <title id="sect0005">Abstract</title> <sec> <p id="spar0005">We successfully established a mass production system for an influenza virus-like particle (VLP) vaccine using a synthetic H5 hemagglutinin (HA) gene codon-optimized for the silkworm. A recombinant baculovirus containing the synthetic gene was inoculated into silkworm pupae. Four days after inoculation, the hemagglutination titer in homogenates from infected pupae reached a mean value of 0.8 million hemagglutination units (HAU), approximately 2, 000 μg HA protein per pupa, more than 50-fold higher than that produced with an embryonated chicken egg. VLPs ranging from 30 nm to 300 nm in diameter and covered with a large number of spikes were detected in the homogenates. The spikes were approximately 14 nm long, similar to an authentic influenza HA spike. Detailed electron micrographs indicated that the VLP spike density was similar to that of authentic influenza virus particles. The results clearly show that the expression of a single HA gene can efficiently produce VLPs in silkworm pupae. When chickens were immunized with the pupae homogenate, the hemagglutination inhibition titer in their sera reached values of 2, 048–8, 192 after approximately 1 month. This is the first report demonstrating that a large amount of VLP vaccine could be produced by single synthetic HA gene in silkworm pupae. Our system might be useful for future vaccine development against other viral<abstract abstract-type="author" id="abs0005"> <title id="sect0005">Abstract</title> <sec> <p id="spar0005">We successfully established a mass production system for an influenza virus-like particle (VLP) vaccine using a synthetic H5 hemagglutinin (HA) gene codon-optimized for the silkworm. A recombinant baculovirus containing the synthetic gene was inoculated into silkworm pupae. Four days after inoculation, the hemagglutination titer in homogenates from infected pupae reached a mean value of 0.8 million hemagglutination units (HAU), approximately 2, 000 μg HA protein per pupa, more than 50-fold higher than that produced with an embryonated chicken egg. VLPs ranging from 30 nm to 300 nm in diameter and covered with a large number of spikes were detected in the homogenates. The spikes were approximately 14 nm long, similar to an authentic influenza HA spike. Detailed electron micrographs indicated that the VLP spike density was similar to that of authentic influenza virus particles. The results clearly show that the expression of a single HA gene can efficiently produce VLPs in silkworm pupae. When chickens were immunized with the pupae homogenate, the hemagglutination inhibition titer in their sera reached values of 2, 048–8, 192 after approximately 1 month. This is the first report demonstrating that a large amount of VLP vaccine could be produced by single synthetic HA gene in silkworm pupae. Our system might be useful for future vaccine development against other viral diseases.</p> </sec> </abstract> … (more)
- Is Part Of:
- Vaccine. Volume 33:Issue 1(2015)
- Journal:
- Vaccine
- Issue:
- Volume 33:Issue 1(2015)
- Issue Display:
- Volume 33, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 33
- Issue:
- 1
- Issue Sort Value:
- 2015-0033-0001-0000
- Page Start:
- 117
- Page End:
- 125
- Publication Date:
- 2015-01-01
- Subjects:
- Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2014.11.009 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3708.xml